Medical management of neurotrophic keratitis

Summary Considerations for the medical management of neurotrophic keratopathy (NK) depend upon the stage/ severity and pathology of the underlying disease process. Therapeutic approaches are broadly divided into strategic areas that encompass categories of treating the underlying disease process, tr...

Full description

Saved in:
Bibliographic Details
Published in:Acta ophthalmologica (Oxford, England) England), 2017-09, Vol.95 (S259), p.n/a
Main Author: RAMA, P.
Format: Article
Language:English
Subjects:
Complications
Keratitis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page n/a
container_issue S259
container_start_page
container_title Acta ophthalmologica (Oxford, England)
container_volume 95
creator RAMA, P.
description Summary Considerations for the medical management of neurotrophic keratopathy (NK) depend upon the stage/ severity and pathology of the underlying disease process. Therapeutic approaches are broadly divided into strategic areas that encompass categories of treating the underlying disease process, treating any concurrent infections, preventing disease progression, promoting epithelialisation, providing tear replacement, reducing inflammation, preventing stromal tissue loss or perforation and avoiding complications.
doi_str_mv 10.1111/j.1755-3768.2017.03323
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1936245091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1936245091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1763-91a4b2906133d3a0f862c3613c73c3f270021c943fccc1fac906caff32578a433</originalsourceid><addsrcrecordid>eNqNkE1LxDAQhoMouK7-BSl4tTXJtEkLXpbFL1jZgwreQpxNtLXb1qRF9t-bWtmzc5kP3meGeQk5ZzRhIa6qhMksi0GKPOGUyYQCcDggs_34cF9nr8fkxPuKUsGESGfk8tFsStR1tNWNfjdb0_RRa6PGDK7tXdt9lBh9Gqf7si_9KTmyuvbm7C_PycvtzfPyPl6t7x6Wi1WMTAqIC6bTN16EEwAb0NTmgiOEDiUgWC4p5QyLFCwiMqsxSFFbCzyTuU4B5uRi2tu59mswvldVO7gmnFSsAMHTjBYsqMSkQtd674xVnSu32u0Uo2p0RlVqfFuNFqjRGfXrTACvJ_C7rM3un5RarJ8m_AcuIGap</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1936245091</pqid></control><display><type>article</type><title>Medical management of neurotrophic keratitis</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>RAMA, P.</creator><creatorcontrib>RAMA, P.</creatorcontrib><description>Summary Considerations for the medical management of neurotrophic keratopathy (NK) depend upon the stage/ severity and pathology of the underlying disease process. Therapeutic approaches are broadly divided into strategic areas that encompass categories of treating the underlying disease process, treating any concurrent infections, preventing disease progression, promoting epithelialisation, providing tear replacement, reducing inflammation, preventing stromal tissue loss or perforation and avoiding complications.</description><identifier>ISSN: 1755-375X</identifier><identifier>EISSN: 1755-3768</identifier><identifier>DOI: 10.1111/j.1755-3768.2017.03323</identifier><language>eng</language><publisher>Malden: Wiley Subscription Services, Inc</publisher><subject>Complications ; Keratitis</subject><ispartof>Acta ophthalmologica (Oxford, England), 2017-09, Vol.95 (S259), p.n/a</ispartof><rights>2017 The Authors Acta Ophthalmologica © 2017 Acta Ophthalmologica Scandinavica Foundation</rights><rights>Copyright © 2017 Acta Ophthalmologica Scandinavica Foundation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>RAMA, P.</creatorcontrib><title>Medical management of neurotrophic keratitis</title><title>Acta ophthalmologica (Oxford, England)</title><description>Summary Considerations for the medical management of neurotrophic keratopathy (NK) depend upon the stage/ severity and pathology of the underlying disease process. Therapeutic approaches are broadly divided into strategic areas that encompass categories of treating the underlying disease process, treating any concurrent infections, preventing disease progression, promoting epithelialisation, providing tear replacement, reducing inflammation, preventing stromal tissue loss or perforation and avoiding complications.</description><subject>Complications</subject><subject>Keratitis</subject><issn>1755-375X</issn><issn>1755-3768</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkE1LxDAQhoMouK7-BSl4tTXJtEkLXpbFL1jZgwreQpxNtLXb1qRF9t-bWtmzc5kP3meGeQk5ZzRhIa6qhMksi0GKPOGUyYQCcDggs_34cF9nr8fkxPuKUsGESGfk8tFsStR1tNWNfjdb0_RRa6PGDK7tXdt9lBh9Gqf7si_9KTmyuvbm7C_PycvtzfPyPl6t7x6Wi1WMTAqIC6bTN16EEwAb0NTmgiOEDiUgWC4p5QyLFCwiMqsxSFFbCzyTuU4B5uRi2tu59mswvldVO7gmnFSsAMHTjBYsqMSkQtd674xVnSu32u0Uo2p0RlVqfFuNFqjRGfXrTACvJ_C7rM3un5RarJ8m_AcuIGap</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>RAMA, P.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>201709</creationdate><title>Medical management of neurotrophic keratitis</title><author>RAMA, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1763-91a4b2906133d3a0f862c3613c73c3f270021c943fccc1fac906caff32578a433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Complications</topic><topic>Keratitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RAMA, P.</creatorcontrib><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Acta ophthalmologica (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RAMA, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medical management of neurotrophic keratitis</atitle><jtitle>Acta ophthalmologica (Oxford, England)</jtitle><date>2017-09</date><risdate>2017</risdate><volume>95</volume><issue>S259</issue><epage>n/a</epage><issn>1755-375X</issn><eissn>1755-3768</eissn><abstract>Summary Considerations for the medical management of neurotrophic keratopathy (NK) depend upon the stage/ severity and pathology of the underlying disease process. Therapeutic approaches are broadly divided into strategic areas that encompass categories of treating the underlying disease process, treating any concurrent infections, preventing disease progression, promoting epithelialisation, providing tear replacement, reducing inflammation, preventing stromal tissue loss or perforation and avoiding complications.</abstract><cop>Malden</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1111/j.1755-3768.2017.03323</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1755-375X
ispartof Acta ophthalmologica (Oxford, England), 2017-09, Vol.95 (S259), p.n/a
issn 1755-375X
1755-3768
language eng
recordid cdi_proquest_journals_1936245091
source Wiley-Blackwell Read & Publish Collection
subjects Complications
Keratitis
title Medical management of neurotrophic keratitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A42%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medical%20management%20of%20neurotrophic%20keratitis&rft.jtitle=Acta%20ophthalmologica%20(Oxford,%20England)&rft.au=RAMA,%20P.&rft.date=2017-09&rft.volume=95&rft.issue=S259&rft.epage=n/a&rft.issn=1755-375X&rft.eissn=1755-3768&rft_id=info:doi/10.1111/j.1755-3768.2017.03323&rft_dat=%3Cproquest_cross%3E1936245091%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1763-91a4b2906133d3a0f862c3613c73c3f270021c943fccc1fac906caff32578a433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1936245091&rft_id=info:pmid/&rfr_iscdi=true